Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

David Lynch

Concepts (949)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Friedreich Ataxia
67
2025
75
22.710
Why?
Tomography, X-Ray Computed
240
2025
2509
22.540
Why?
Lung Diseases, Interstitial
85
2025
592
12.000
Why?
Pulmonary Disease, Chronic Obstructive
97
2025
944
11.340
Why?
Pulmonary Emphysema
63
2024
244
10.210
Why?
Idiopathic Pulmonary Fibrosis
58
2025
623
7.730
Why?
Lung
135
2025
3745
6.560
Why?
Pulmonary Fibrosis
31
2025
377
5.380
Why?
Iron-Binding Proteins
30
2025
40
4.820
Why?
Lung Diseases
29
2023
713
4.170
Why?
Emphysema
16
2024
94
3.690
Why?
Smoking
58
2024
1459
3.610
Why?
Radiography, Thoracic
25
2024
163
2.990
Why?
Humans
444
2025
128020
2.940
Why?
Alveolitis, Extrinsic Allergic
14
2023
92
2.560
Why?
Lung Neoplasms
30
2023
2327
2.510
Why?
Middle Aged
209
2025
30813
2.500
Why?
Smokers
17
2024
137
2.420
Why?
Idiopathic Interstitial Pneumonias
14
2019
49
2.290
Why?
Male
254
2025
62758
2.220
Why?
Disease Progression
51
2024
2598
2.180
Why?
Aged
167
2025
21892
2.170
Why?
Diagnostic Imaging
10
2024
329
2.080
Why?
Female
250
2025
68017
2.040
Why?
Trinucleotide Repeat Expansion
13
2024
26
1.940
Why?
Severity of Illness Index
50
2024
2703
1.900
Why?
Receptors, N-Methyl-D-Aspartate
10
2021
200
1.860
Why?
Forced Expiratory Volume
38
2024
509
1.820
Why?
Pattern Recognition, Automated
4
2018
72
1.790
Why?
Biopsy
27
2023
1077
1.770
Why?
Diagnosis, Differential
41
2024
1408
1.710
Why?
Mucin-5B
11
2025
217
1.600
Why?
Cohort Studies
46
2025
5378
1.590
Why?
Triterpenes
2
2023
20
1.430
Why?
Respiratory Function Tests
30
2024
580
1.420
Why?
Adult
110
2025
35177
1.380
Why?
Connective Tissue Diseases
9
2019
80
1.330
Why?
Image Processing, Computer-Assisted
11
2025
734
1.320
Why?
Quality of Life
23
2024
2672
1.320
Why?
Radiographic Image Interpretation, Computer-Assisted
11
2017
96
1.320
Why?
Reproducibility of Results
40
2024
3009
1.310
Why?
Vital Capacity
25
2024
289
1.310
Why?
Bronchiectasis
10
2024
108
1.290
Why?
Incidental Findings
3
2021
79
1.270
Why?
Heterozygote
6
2024
267
1.260
Why?
Phenotype
24
2025
3039
1.250
Why?
Troponin I
2
2024
75
1.230
Why?
Pulmonary Artery
7
2024
1030
1.210
Why?
Magnetic Resonance Imaging
18
2023
3371
1.140
Why?
Aged, 80 and over
50
2021
7029
1.130
Why?
Early Detection of Cancer
9
2023
369
1.100
Why?
Sarcoidosis
3
2025
154
1.100
Why?
Heart Diseases
3
2024
345
1.080
Why?
Occupational Diseases
5
2015
138
1.050
Why?
Vision Disorders
2
2020
135
1.010
Why?
Spirometry
25
2024
252
1.000
Why?
Sarcoidosis, Pulmonary
5
2025
79
0.990
Why?
Respiratory System Abnormalities
2
2022
16
0.990
Why?
Young Adult
31
2024
12282
0.990
Why?
NF-E2-Related Factor 2
3
2023
67
0.970
Why?
Antioxidants
4
2014
542
0.970
Why?
Retrospective Studies
54
2024
14404
0.960
Why?
Schizophrenia
4
2022
428
0.950
Why?
Cerebellum
3
2025
217
0.950
Why?
Common Variable Immunodeficiency
3
2018
27
0.920
Why?
Sinusitis
3
2023
202
0.920
Why?
Biomarkers
16
2025
3874
0.920
Why?
Sensitivity and Specificity
25
2021
1813
0.900
Why?
Positron-Emission Tomography
5
2018
283
0.890
Why?
Lymph Nodes
2
2019
465
0.890
Why?
Adolescent
40
2024
20158
0.880
Why?
Cystic Fibrosis
8
2023
1048
0.870
Why?
Paranasal Sinuses
3
2023
74
0.870
Why?
Trinucleotide Repeats
5
2023
25
0.870
Why?
Natriuretic Peptide, Brain
1
2024
99
0.870
Why?
Predictive Value of Tests
13
2024
1934
0.870
Why?
Lung Injury
2
2024
199
0.850
Why?
Respiratory-Gated Imaging Techniques
3
2017
10
0.840
Why?
Prognosis
24
2024
3766
0.820
Why?
Pulmonary Diffusing Capacity
11
2024
74
0.810
Why?
Linoleic Acid
1
2022
41
0.810
Why?
Neurons
9
2018
1445
0.800
Why?
Ubiquinone
3
2011
28
0.800
Why?
Cardiomyopathies
4
2024
335
0.790
Why?
Anthracosis
1
2022
10
0.780
Why?
Multiple Pulmonary Nodules
2
2019
19
0.750
Why?
Double-Blind Method
15
2024
1852
0.750
Why?
Homeostasis
2
2016
605
0.740
Why?
Calpain
4
2007
55
0.740
Why?
Algorithms
11
2024
1609
0.710
Why?
Calcinosis
1
2022
230
0.700
Why?
Neurodegenerative Diseases
1
2022
110
0.700
Why?
Ataxia
3
2023
41
0.680
Why?
Case-Control Studies
23
2020
3324
0.670
Why?
Visual Acuity
2
2020
322
0.670
Why?
Longitudinal Studies
17
2023
2706
0.650
Why?
Child
37
2024
20636
0.640
Why?
Dyspnea
5
2023
238
0.640
Why?
Ventricular Dysfunction, Left
2
2013
383
0.630
Why?
Machine Learning
9
2020
442
0.630
Why?
Genotype
14
2025
1828
0.600
Why?
Muscle, Smooth, Vascular
1
2021
418
0.600
Why?
Prospective Studies
28
2024
7035
0.600
Why?
Bronchitis, Chronic
4
2023
19
0.580
Why?
Collagen Diseases
3
2012
6
0.570
Why?
Mass Screening
8
2023
1145
0.570
Why?
Anti-N-Methyl-D-Aspartate Receptor Encephalitis
1
2017
16
0.570
Why?
Bronchiolitis
5
2015
87
0.570
Why?
Risk Factors
33
2024
9696
0.570
Why?
Thoracic Diseases
2
2015
14
0.570
Why?
Follow-Up Studies
21
2024
4853
0.550
Why?
Arthritis, Rheumatoid
7
2024
1088
0.550
Why?
Occupational Exposure
7
2020
299
0.550
Why?
Interdisciplinary Communication
2
2016
185
0.540
Why?
Interferon-gamma
2
2019
760
0.540
Why?
Patient Satisfaction
1
2021
624
0.530
Why?
Immunoassay
3
2014
103
0.530
Why?
Observer Variation
11
2021
310
0.530
Why?
Bronchi
3
2024
241
0.520
Why?
alpha7 Nicotinic Acetylcholine Receptor
2
2014
101
0.520
Why?
Mental Health Services
1
2021
400
0.510
Why?
Genetic Predisposition to Disease
20
2020
2261
0.510
Why?
Echocardiography
4
2017
623
0.500
Why?
Opsoclonus-Myoclonus Syndrome
1
2015
1
0.500
Why?
Antigens, Surface
2
2015
150
0.500
Why?
Asthma
7
2023
2212
0.490
Why?
Mitochondria
4
2020
847
0.490
Why?
Genome-Wide Association Study
12
2020
1330
0.490
Why?
Dendrites
2
2018
100
0.490
Why?
Telemedicine
2
2021
781
0.490
Why?
Metabolic Diseases
1
2016
104
0.480
Why?
Mycobacterium avium-intracellulare Infection
1
2016
61
0.470
Why?
Cells, Cultured
11
2021
4006
0.470
Why?
Airway Remodeling
7
2021
58
0.470
Why?
Tomography, Spiral Computed
5
2013
27
0.460
Why?
NF-kappa B
1
2018
649
0.460
Why?
Patient Acceptance of Health Care
1
2021
756
0.460
Why?
Pneumonia, Bacterial
1
2016
111
0.460
Why?
Nerve Tissue Proteins
6
2018
569
0.460
Why?
Parvalbumins
1
2014
22
0.450
Why?
Polymorphism, Single Nucleotide
10
2018
2059
0.450
Why?
Mutation
9
2024
3682
0.450
Why?
Lymphatic Diseases
1
2014
21
0.450
Why?
Olfaction Disorders
3
2024
60
0.450
Why?
Vascular Diseases
2
2009
232
0.440
Why?
Radiographic Image Enhancement
5
2020
52
0.440
Why?
Mass Spectrometry
7
2023
662
0.440
Why?
Mouth Mucosa
2
2014
89
0.440
Why?
Regression Analysis
11
2019
978
0.440
Why?
Nervous System Diseases
3
2007
251
0.430
Why?
Autoantibodies
7
2015
1461
0.430
Why?
Polymorphism, Genetic
4
2017
638
0.430
Why?
gamma-Aminobutyric Acid
1
2014
157
0.420
Why?
Support Vector Machine
1
2013
36
0.420
Why?
Spinocerebellar Degenerations
2
2023
5
0.410
Why?
Sequence Analysis, RNA
5
2018
427
0.410
Why?
Elasticity Imaging Techniques
1
2013
47
0.410
Why?
Risk Assessment
9
2025
3223
0.410
Why?
United States
33
2024
13785
0.410
Why?
Cerebellar Ataxia
2
2023
10
0.410
Why?
Receptor for Advanced Glycation End Products
3
2022
30
0.400
Why?
Health Status
6
2023
747
0.400
Why?
Angiography
2
2013
192
0.400
Why?
Treatment Outcome
18
2024
10110
0.400
Why?
Neuronal Plasticity
3
2010
263
0.400
Why?
Radiation Dosage
7
2024
151
0.390
Why?
Exhalation
3
2018
38
0.390
Why?
Receptors, Nicotinic
3
2015
323
0.390
Why?
Heart Failure
2
2024
2141
0.390
Why?
Exercise Test
5
2024
613
0.380
Why?
Vena Cava, Superior
1
2012
22
0.380
Why?
Point Mutation
4
2014
221
0.380
Why?
Asymptomatic Diseases
1
2012
83
0.380
Why?
Osteosarcoma
1
2012
72
0.370
Why?
Databases, Factual
3
2024
1264
0.370
Why?
Pandemics
5
2024
1473
0.370
Why?
Comorbidity
9
2018
1537
0.370
Why?
Animals
26
2025
34487
0.370
Why?
Genetic Variation
4
2019
933
0.360
Why?
Rhinitis
2
2023
148
0.360
Why?
Glucose
1
2016
983
0.360
Why?
Cystic Fibrosis Transmembrane Conductance Regulator
4
2022
312
0.360
Why?
Echocardiography, Doppler
1
2011
108
0.360
Why?
Imaging, Three-Dimensional
5
2021
529
0.360
Why?
Respiratory Tract Diseases
3
2018
148
0.360
Why?
Hypertrophy, Left Ventricular
1
2011
126
0.350
Why?
Doxorubicin
1
2012
322
0.350
Why?
Pulmonary Embolism
2
2012
202
0.350
Why?
Chronic Disease
9
2024
1690
0.350
Why?
Heart Transplantation
1
2017
711
0.350
Why?
Cysts
3
2023
108
0.340
Why?
Dysarthria
1
2010
9
0.340
Why?
Survival Analysis
7
2020
1262
0.340
Why?
Myocardial Contraction
1
2011
333
0.340
Why?
Presynaptic Terminals
1
2010
68
0.330
Why?
Child, Preschool
13
2024
10378
0.330
Why?
Image Interpretation, Computer-Assisted
4
2020
253
0.330
Why?
Bone Neoplasms
1
2012
229
0.330
Why?
Mice, Inbred C57BL
7
2025
5268
0.330
Why?
Encephalitis
2
2008
132
0.330
Why?
Stroke Volume
2
2017
588
0.330
Why?
Pulmonary Atelectasis
3
2018
13
0.330
Why?
Multivariate Analysis
10
2019
1492
0.330
Why?
Hyperostosis, Diffuse Idiopathic Skeletal
2
2019
4
0.320
Why?
Gene Expression Regulation, Developmental
1
2014
817
0.320
Why?
Lung Volume Measurements
4
2024
43
0.320
Why?
Gadolinium
4
2020
77
0.310
Why?
Cross-Sectional Studies
13
2024
5034
0.310
Why?
Tomography, Emission-Computed
2
2006
66
0.310
Why?
Artificial Intelligence
3
2025
244
0.300
Why?
ROC Curve
5
2019
500
0.300
Why?
Surveys and Questionnaires
11
2021
5353
0.300
Why?
Autoimmune Diseases of the Nervous System
1
2008
24
0.300
Why?
Fibroblasts
6
2022
934
0.300
Why?
Birt-Hogg-Dube Syndrome
4
2023
7
0.300
Why?
Bronchioles
2
2019
22
0.300
Why?
Feasibility Studies
5
2018
860
0.300
Why?
Radiology
2
2014
161
0.300
Why?
Practice Guidelines as Topic
4
2021
1482
0.290
Why?
Blood Platelets
3
2018
376
0.290
Why?
Linear Models
8
2018
816
0.290
Why?
Histiocytosis, Langerhans-Cell
4
2023
36
0.290
Why?
Receptors, AMPA
2
2025
133
0.290
Why?
Analysis of Variance
5
2014
1266
0.290
Why?
Dose-Response Relationship, Drug
4
2018
1943
0.290
Why?
Clinical Decision-Making
2
2021
302
0.290
Why?
Cerebral Cortex
5
2018
422
0.290
Why?
Sex Factors
5
2018
1942
0.280
Why?
Nitrogen Dioxide
1
2007
33
0.280
Why?
Siblings
1
2008
215
0.280
Why?
Pseudomonas Infections
1
2009
218
0.280
Why?
Schizophrenic Psychology
3
2022
93
0.280
Why?
Respiration
5
2023
190
0.280
Why?
Body Mass Index
7
2018
2260
0.270
Why?
Mice
12
2025
16574
0.270
Why?
alpha 1-Antitrypsin Deficiency
2
2023
60
0.270
Why?
Acute Disease
6
2021
961
0.260
Why?
Receptors, Metabotropic Glutamate
1
2007
39
0.260
Why?
Consensus
2
2023
607
0.260
Why?
Total Lung Capacity
7
2020
33
0.260
Why?
Neurologic Examination
3
2012
115
0.260
Why?
Chromatography, Liquid
4
2018
377
0.260
Why?
Bronchography
3
2013
10
0.260
Why?
Autoimmune Diseases
2
2024
423
0.260
Why?
Synapses
2
2009
383
0.260
Why?
Alleles
6
2019
842
0.260
Why?
Lymphangioleiomyomatosis
3
2023
34
0.260
Why?
Protein Subunits
3
2021
230
0.260
Why?
Blotting, Western
5
2019
1169
0.250
Why?
Prevalence
10
2024
2541
0.250
Why?
Carcinoma, Non-Small-Cell Lung
2
2011
1045
0.250
Why?
Airway Obstruction
2
2019
149
0.240
Why?
Early Diagnosis
5
2021
234
0.240
Why?
Walking
3
2022
495
0.240
Why?
Mycobacterium Infections
1
2005
61
0.240
Why?
Pregnancy Complications
1
2010
487
0.240
Why?
Solitary Pulmonary Nodule
3
2016
20
0.240
Why?
Age Factors
5
2015
3100
0.240
Why?
beta Catenin
1
2007
217
0.240
Why?
Genetic Association Studies
2
2019
361
0.240
Why?
Hippocampus
3
2009
801
0.230
Why?
Bronchial Arteries
1
2024
12
0.230
Why?
Heart Defects, Congenital
1
2012
747
0.230
Why?
Recombinant Proteins
3
2019
1286
0.230
Why?
Hypoxia
1
2012
1034
0.230
Why?
Radiopharmaceuticals
2
2016
166
0.230
Why?
Logistic Models
10
2018
1975
0.230
Why?
Protein Isoforms
3
2019
377
0.230
Why?
Proportional Hazards Models
6
2024
1194
0.230
Why?
Diaphragm
1
2024
43
0.230
Why?
Patient Positioning
1
2024
52
0.230
Why?
Patient Care Team
2
2016
597
0.230
Why?
Purkinje Cells
1
2025
67
0.230
Why?
Dopamine
2
2006
285
0.230
Why?
p38 Mitogen-Activated Protein Kinases
1
2005
268
0.220
Why?
Mucus
1
2025
75
0.220
Why?
Blood Glucose
1
2014
2092
0.220
Why?
Time Factors
10
2024
6479
0.220
Why?
Embryo, Mammalian
2
2015
226
0.220
Why?
Gene Expression Regulation, Enzymologic
1
2005
281
0.220
Why?
Troponin T
1
2024
57
0.220
Why?
Introns
2
2023
249
0.220
Why?
Cluster Analysis
4
2019
477
0.220
Why?
Tropanes
1
2003
5
0.220
Why?
Organotechnetium Compounds
1
2003
10
0.220
Why?
Survival Rate
6
2018
1870
0.210
Why?
Molecular Epidemiology
2
2022
63
0.210
Why?
Patient Advocacy
1
2024
73
0.210
Why?
Rats
6
2015
5199
0.210
Why?
International Cooperation
4
2017
171
0.210
Why?
Blood Proteins
1
2025
239
0.210
Why?
Incidence
9
2023
2614
0.210
Why?
Disease Models, Animal
3
2025
3936
0.210
Why?
Contrast Media
3
2020
387
0.210
Why?
Tomography, Emission-Computed, Single-Photon
1
2003
76
0.210
Why?
Motivation
3
2022
544
0.210
Why?
Linoleic Acids
1
2022
4
0.210
Why?
Mitochondrial Proteins
2
2023
245
0.210
Why?
Models, Biological
4
2017
1689
0.200
Why?
Corpus Striatum
2
2006
155
0.200
Why?
Membrane Glycoproteins
2
2015
467
0.200
Why?
Smell
1
2023
132
0.200
Why?
Age of Onset
6
2019
490
0.200
Why?
Carcinogens, Environmental
1
2002
7
0.200
Why?
Perioperative Care
1
2024
149
0.200
Why?
Clinical Trials as Topic
6
2024
997
0.200
Why?
Pneumoconiosis
1
2002
19
0.200
Why?
Promoter Regions, Genetic
5
2019
1198
0.200
Why?
Asbestos
1
2002
28
0.200
Why?
Antibodies
2
2019
392
0.200
Why?
Delphi Technique
1
2023
221
0.200
Why?
Ventricular Function
2
2017
61
0.200
Why?
Sjogren's Syndrome
3
2019
47
0.200
Why?
Chi-Square Distribution
5
2013
511
0.200
Why?
Guanine
3
2022
76
0.200
Why?
Diabetes Mellitus
3
2016
994
0.200
Why?
Membrane Transport Proteins
1
2003
148
0.190
Why?
Bleomycin
3
2021
240
0.190
Why?
Mesothelioma
1
2002
38
0.190
Why?
Hypertension, Pulmonary
5
2021
1747
0.190
Why?
Aftercare
1
2024
206
0.190
Why?
Bronchial Diseases
2
2012
38
0.190
Why?
Genetic Therapy
2
2021
290
0.190
Why?
Chromosome Deletion
2
2015
102
0.190
Why?
Tomography Scanners, X-Ray Computed
2
2017
19
0.190
Why?
Environmental Exposure
4
2020
458
0.190
Why?
Peptide Hydrolases
1
2002
106
0.190
Why?
Cyclophosphamide
3
2011
227
0.190
Why?
Societies, Medical
8
2021
741
0.190
Why?
Fibrosis
7
2022
513
0.190
Why?
Carbon Monoxide
3
2019
68
0.180
Why?
Symptom Flare Up
1
2021
38
0.180
Why?
Retinoids
1
2021
33
0.180
Why?
Respiration Disorders
1
2021
72
0.180
Why?
Spinal Fusion
1
2024
230
0.180
Why?
Protein C
1
2021
41
0.180
Why?
Pulmonary Surfactant-Associated Protein C
1
2021
43
0.180
Why?
Scleroderma, Systemic
3
2019
102
0.180
Why?
Statistics as Topic
4
2012
303
0.180
Why?
Intensive Care Units, Neonatal
1
2024
222
0.180
Why?
RNA Stability
1
2021
100
0.180
Why?
Angiotensin Receptor Antagonists
1
2021
89
0.180
Why?
Protein Kinase Inhibitors
3
2022
875
0.180
Why?
DNA
2
2018
1392
0.180
Why?
Genetic Testing
2
2008
428
0.170
Why?
RNA, Messenger
5
2021
2669
0.170
Why?
Bacteriophages
1
2022
92
0.170
Why?
Brain
3
2020
2615
0.170
Why?
Patient Care Management
1
2021
56
0.170
Why?
Mycobacterium abscessus
1
2022
104
0.170
Why?
Pulmonary Medicine
3
2015
78
0.170
Why?
Adenine
3
2022
255
0.170
Why?
Intermediate Filaments
1
2020
27
0.170
Why?
Cognitive Remediation
1
2020
1
0.170
Why?
Mice, Knockout
2
2025
2757
0.170
Why?
Psychiatric Status Rating Scales
1
2022
520
0.170
Why?
Angiotensin-Converting Enzyme Inhibitors
1
2021
198
0.170
Why?
Rare Diseases
2
2018
100
0.170
Why?
Teratoma
3
2010
103
0.170
Why?
Health Resources
1
2021
112
0.170
Why?
Neurofilament Proteins
1
2020
43
0.170
Why?
Vasoconstriction
1
2021
185
0.170
Why?
Pneumonia
5
2013
600
0.170
Why?
Pilot Projects
2
2022
1559
0.160
Why?
Hyperostosis
1
2019
5
0.160
Why?
Desmoplakins
1
2019
19
0.160
Why?
Sensorimotor Cortex
1
2019
5
0.160
Why?
Afferent Pathways
1
2019
43
0.160
Why?
Genetic Markers
3
2021
338
0.160
Why?
Cigarette Smoking
2
2020
87
0.160
Why?
DiGeorge Syndrome
2
2012
29
0.160
Why?
Myocytes, Smooth Muscle
1
2021
245
0.160
Why?
Proprioception
1
2019
26
0.160
Why?
Communication
2
2024
838
0.160
Why?
Ambulatory Care Facilities
1
2021
226
0.160
Why?
Racemases and Epimerases
1
2018
11
0.160
Why?
Models, Theoretical
2
2020
541
0.150
Why?
Proteomics
3
2025
1008
0.150
Why?
Minimal Clinically Important Difference
1
2018
13
0.150
Why?
Iron Regulatory Protein 2
2
2015
5
0.150
Why?
Sex Distribution
5
2016
356
0.150
Why?
Parkinson Disease
2
2006
460
0.150
Why?
Oral Hygiene
1
2018
17
0.150
Why?
Scleroderma, Limited
2
2008
5
0.150
Why?
Cause of Death
2
2018
392
0.150
Why?
Genetic Loci
3
2016
274
0.150
Why?
Psychometrics
1
2022
679
0.150
Why?
Indoles
2
2019
371
0.150
Why?
Randomized Controlled Trials as Topic
4
2022
1356
0.150
Why?
Membrane Proteins
2
2015
1105
0.150
Why?
Drug-Related Side Effects and Adverse Reactions
1
2021
251
0.150
Why?
Carrier Proteins
3
2015
730
0.150
Why?
Apolipoprotein A-I
1
2018
28
0.150
Why?
Self-Help Devices
1
2018
18
0.150
Why?
September 11 Terrorist Attacks
1
2018
31
0.150
Why?
Air Pollutants, Occupational
1
2018
32
0.150
Why?
Societies
1
2017
36
0.140
Why?
Traction
3
2023
19
0.140
Why?
Molecular Targeted Therapy
1
2021
384
0.140
Why?
Fatigue
1
2019
316
0.140
Why?
Vascular Calcification
1
2019
107
0.140
Why?
Respiratory System
2
2016
152
0.140
Why?
Pleura
2
2015
22
0.140
Why?
Genomic Instability
1
2017
47
0.140
Why?
Cryptogenic Organizing Pneumonia
2
2009
17
0.140
Why?
Spine
1
2019
156
0.140
Why?
Motion
1
2017
98
0.140
Why?
Cardiac Volume
1
2017
12
0.140
Why?
Premature Birth
2
2012
310
0.140
Why?
Mycobacterium Infections, Nontuberculous
1
2022
348
0.140
Why?
Principal Component Analysis
1
2017
182
0.140
Why?
Parenchymal Tissue
1
2016
6
0.140
Why?
Complement C3
1
2018
198
0.140
Why?
Bronchiolitis Obliterans
2
2009
64
0.130
Why?
Evidence-Based Medicine
3
2021
709
0.130
Why?
Data Interpretation, Statistical
1
2018
335
0.130
Why?
Nursing Homes
1
2018
154
0.130
Why?
Bayes Theorem
2
2022
369
0.130
Why?
Computed Tomography Angiography
1
2018
115
0.130
Why?
Calibration
1
2017
135
0.130
Why?
Program Evaluation
1
2021
872
0.130
Why?
Creatine
1
2016
55
0.130
Why?
Mucociliary Clearance
1
2016
42
0.130
Why?
Arthritis, Experimental
1
2018
128
0.130
Why?
Pulmonary Alveoli
2
2016
365
0.130
Why?
Software Validation
1
2016
9
0.130
Why?
HLA-DQ beta-Chains
1
2016
61
0.130
Why?
Gene Regulatory Networks
1
2018
279
0.130
Why?
Respiratory Insufficiency
2
2017
311
0.130
Why?
Republic of Korea
3
2023
28
0.130
Why?
Loss of Heterozygosity
1
2016
46
0.130
Why?
Tracheal Diseases
1
2016
16
0.130
Why?
Chromosomes, Human, Pair 5
1
2015
29
0.130
Why?
Mitochondrial Diseases
1
2016
88
0.130
Why?
Pleural Diseases
1
2015
17
0.130
Why?
Reference Values
3
2013
776
0.130
Why?
Referral and Consultation
1
2021
724
0.120
Why?
HLA-DRB1 Chains
1
2016
108
0.120
Why?
Genomics
1
2021
714
0.120
Why?
Guanylate Kinases
1
2015
13
0.120
Why?
Neoplasm Staging
3
2011
1288
0.120
Why?
ELAV Proteins
1
2015
14
0.120
Why?
Collagen
1
2018
429
0.120
Why?
Oxidative Phosphorylation
1
2016
184
0.120
Why?
Disks Large Homolog 4 Protein
1
2015
16
0.120
Why?
Azathioprine
1
2015
49
0.120
Why?
Sildenafil Citrate
1
2015
59
0.120
Why?
Gene Expression Regulation
4
2018
2508
0.120
Why?
Transcription Elongation, Genetic
1
2015
22
0.120
Why?
Military Personnel
1
2022
513
0.120
Why?
Cell Line
4
2016
2736
0.120
Why?
Pneumonia, Viral
1
2020
337
0.120
Why?
Electrocardiography
3
2017
607
0.120
Why?
Interferon-beta
2
2008
87
0.120
Why?
Occupational Health
1
2018
192
0.120
Why?
Protein Biosynthesis
1
2017
397
0.120
Why?
Coronavirus Infections
1
2020
333
0.120
Why?
Inflammation Mediators
1
2018
495
0.120
Why?
Multicenter Studies as Topic
2
2014
285
0.120
Why?
Galactosylceramidase
1
2015
3
0.120
Why?
Patient Selection
2
2020
658
0.120
Why?
Receptors, GABA-A
2
2014
97
0.120
Why?
Cryopreservation
1
2016
97
0.120
Why?
Mycobacterium avium Complex
1
2016
85
0.120
Why?
Glucose Tolerance Test
1
2016
356
0.120
Why?
Cognitive Dysfunction
1
2020
343
0.120
Why?
Epithelial Cells
1
2021
1037
0.120
Why?
Comparative Effectiveness Research
1
2016
146
0.120
Why?
Axonemal Dyneins
1
2014
9
0.120
Why?
Adenocarcinoma
2
2012
888
0.120
Why?
Brain Stem
1
2015
98
0.120
Why?
DNA Copy Number Variations
1
2015
169
0.120
Why?
Pyridones
2
2023
158
0.120
Why?
Kaplan-Meier Estimate
2
2015
851
0.120
Why?
Gene Silencing
1
2015
183
0.120
Why?
Transcriptome
2
2018
879
0.120
Why?
Prednisone
1
2015
230
0.120
Why?
Physicians
2
2022
858
0.110
Why?
Antibodies, Monoclonal, Humanized
1
2019
754
0.110
Why?
Inhibitory Postsynaptic Potentials
1
2014
32
0.110
Why?
Tyrosine
2
2005
218
0.110
Why?
Spinal Fractures
1
2015
81
0.110
Why?
Myocardium
1
2019
967
0.110
Why?
Immunosuppressive Agents
3
2015
682
0.110
Why?
Catechol O-Methyltransferase
2
2004
18
0.110
Why?
Phosphatidylinositol 3-Kinases
2
2007
356
0.110
Why?
Birth Weight
2
2024
499
0.110
Why?
Mass Chest X-Ray
2
2010
4
0.110
Why?
Glutamate Decarboxylase
1
2014
166
0.110
Why?
Excitatory Amino Acid Antagonists
2
2005
92
0.110
Why?
Age Distribution
3
2016
369
0.110
Why?
Membrane Potentials
1
2014
261
0.110
Why?
Infant
6
2024
8912
0.110
Why?
Contrast Sensitivity
1
2013
13
0.110
Why?
Multidetector Computed Tomography
3
2019
32
0.110
Why?
Heart Ventricles
2
2017
765
0.110
Why?
Anisotropy
1
2013
70
0.110
Why?
Matrix Metalloproteinase 7
1
2013
25
0.110
Why?
Erythrocytes
1
2018
673
0.100
Why?
Qc-SNARE Proteins
1
2012
7
0.100
Why?
Qb-SNARE Proteins
1
2012
6
0.100
Why?
Inflammation
4
2018
2646
0.100
Why?
Research Design
3
2022
1034
0.100
Why?
Protons
1
2013
80
0.100
Why?
Liver
2
2020
1826
0.100
Why?
Antineoplastic Combined Chemotherapy Protocols
2
2012
1558
0.100
Why?
Elastic Modulus
1
2013
123
0.100
Why?
Respiratory Mechanics
1
2013
63
0.100
Why?
Iopamidol
1
2012
16
0.100
Why?
Carcinoma, Bronchogenic
2
2002
19
0.100
Why?
JNK Mitogen-Activated Protein Kinases
2
2024
160
0.100
Why?
Coronary Artery Disease
1
2019
675
0.100
Why?
Radiologists
2
2024
41
0.100
Why?
Blood Cells
1
2012
38
0.100
Why?
Fasting
1
2014
264
0.100
Why?
Histocompatibility Antigens Class I
1
2014
196
0.100
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
2
2018
410
0.100
Why?
Dextrocardia
1
2012
3
0.100
Why?
Ventricular Dysfunction
1
2012
15
0.100
Why?
Osteoporosis
1
2015
233
0.100
Why?
Mental Disorders
1
2020
1005
0.100
Why?
Animals, Newborn
1
2014
801
0.100
Why?
Paraneoplastic Syndromes, Nervous System
2
2008
12
0.090
Why?
Blood Vessels
1
2013
181
0.090
Why?
Antibiotics, Antineoplastic
1
2012
120
0.090
Why?
Cilia
1
2013
178
0.090
Why?
Tomography, Optical Coherence
1
2013
186
0.090
Why?
Bronchoscopy
3
2021
208
0.090
Why?
Diastole
1
2011
148
0.090
Why?
Sarcoma, Kaposi
1
2012
76
0.090
Why?
Stress, Mechanical
1
2013
460
0.090
Why?
Sodium Chloride
1
2012
138
0.090
Why?
Bone Density
1
2015
474
0.090
Why?
Heart Atria
1
2012
127
0.090
Why?
Methotrexate
1
2012
249
0.090
Why?
Mice, Transgenic
2
2014
2066
0.090
Why?
Miniature Postsynaptic Potentials
1
2010
9
0.090
Why?
Clinical Trials, Phase II as Topic
2
2022
72
0.090
Why?
Apgar Score
1
2010
16
0.090
Why?
Term Birth
1
2010
20
0.090
Why?
Inflammasomes
1
2012
124
0.090
Why?
Cisplatin
1
2012
297
0.090
Why?
Peptides, Cyclic
1
2012
255
0.090
Why?
Hemoptysis
1
2010
33
0.080
Why?
Speech Disorders
1
2010
34
0.080
Why?
Live Birth
1
2010
56
0.080
Why?
Leg
1
2012
236
0.080
Why?
Registries
2
2017
1873
0.080
Why?
Scleroderma, Localized
1
2009
8
0.080
Why?
Excitatory Postsynaptic Potentials
1
2010
112
0.080
Why?
Polymyositis
1
2009
14
0.080
Why?
Aminophenols
2
2022
144
0.080
Why?
Autoimmunity
2
2015
860
0.080
Why?
Acute Lung Injury
1
2013
264
0.080
Why?
Aorta
1
2012
408
0.080
Why?
Hepatectomy
1
2011
209
0.080
Why?
Walk Test
2
2021
70
0.080
Why?
Patch-Clamp Techniques
1
2010
260
0.080
Why?
Chromosomes, Human, Pair 22
2
2006
41
0.080
Why?
Gene Expression Profiling
4
2018
1681
0.080
Why?
X-Ray Microtomography
2
2021
84
0.080
Why?
Reactive Oxygen Species
1
2012
582
0.080
Why?
Abortion, Spontaneous
1
2010
99
0.080
Why?
Salivary Glands, Minor
1
2009
9
0.080
Why?
Limbic Encephalitis
1
2009
4
0.080
Why?
Survivors
1
2013
462
0.080
Why?
alpha-Synuclein
2
2006
32
0.080
Why?
Antibodies, Antinuclear
1
2009
66
0.080
Why?
Amino Acyl-tRNA Synthetases
1
2009
30
0.080
Why?
Up-Regulation
1
2012
822
0.080
Why?
Speech
1
2010
74
0.080
Why?
Delivery, Obstetric
1
2010
137
0.080
Why?
Iron Chelating Agents
1
2009
17
0.080
Why?
Exercise Tolerance
3
2016
271
0.080
Why?
Autoantigens
2
2009
416
0.080
Why?
Spondylitis, Ankylosing
1
2009
46
0.080
Why?
Neurocognitive Disorders
1
2008
22
0.080
Why?
Axons
1
2010
188
0.080
Why?
Fluorodeoxyglucose F18
2
2016
127
0.080
Why?
Radiography
4
2004
794
0.080
Why?
Scleroderma, Diffuse
1
2008
4
0.080
Why?
DNA, Mitochondrial
1
2010
188
0.080
Why?
Patient Reported Outcome Measures
2
2022
368
0.080
Why?
Tandem Repeat Sequences
1
2008
18
0.080
Why?
Arrhythmias, Cardiac
1
2011
314
0.080
Why?
Tobacco Use Disorder
1
2011
237
0.080
Why?
Calcium Signaling
1
2010
231
0.070
Why?
Europe
3
2015
359
0.070
Why?
Hereditary Central Nervous System Demyelinating Diseases
1
2008
2
0.070
Why?
Eukaryotic Initiation Factor-2B
1
2008
6
0.070
Why?
Combined Modality Therapy
1
2011
1199
0.070
Why?
Organophosphorus Compounds
1
2009
79
0.070
Why?
Transfection
3
2009
891
0.070
Why?
Hospitalization
2
2014
2057
0.070
Why?
Erythropoietin
1
2009
84
0.070
Why?
Insulin
3
2014
2316
0.070
Why?
Cardiomyopathy, Dilated
1
2011
378
0.070
Why?
Infant, Newborn
3
2024
5688
0.070
Why?
Genetic Heterogeneity
1
2008
57
0.070
Why?
Neurotoxins
1
2007
26
0.070
Why?
Cytoprotection
1
2007
50
0.070
Why?
Catheter Ablation
1
2011
333
0.070
Why?
National Institutes of Health (U.S.)
2
2024
122
0.070
Why?
Area Under Curve
2
2018
288
0.070
Why?
Community Medicine
1
2007
5
0.070
Why?
Sulfonamides
1
2011
494
0.070
Why?
Antihypertensive Agents
1
2011
481
0.070
Why?
Histone Deacetylase Inhibitors
1
2009
207
0.070
Why?
Phosphorylation
2
2016
1681
0.070
Why?
DNA Methylation
1
2012
604
0.070
Why?
Japan
2
2021
96
0.070
Why?
Lupus Erythematosus, Systemic
1
2009
244
0.070
Why?
Pericardium
1
2007
54
0.070
Why?
Activities of Daily Living
1
2010
381
0.070
Why?
Muscle, Skeletal
1
2016
1620
0.070
Why?
Brain Diseases
1
2008
136
0.070
Why?
Cyclin-Dependent Kinase 5
1
2006
3
0.070
Why?
Neuroprotective Agents
1
2007
109
0.070
Why?
Ovarian Neoplasms
2
2010
487
0.070
Why?
Sodium-Calcium Exchanger
1
2006
16
0.070
Why?
Inositol 1,4,5-Trisphosphate Receptors
1
2006
28
0.070
Why?
Epitopes
1
2008
466
0.070
Why?
Statistics, Nonparametric
1
2007
419
0.070
Why?
Pneumonectomy
2
2023
151
0.060
Why?
Internationality
2
2017
149
0.060
Why?
United Kingdom
2
2019
258
0.060
Why?
Antineoplastic Agents
2
2019
2041
0.060
Why?
Carcinoma, Squamous Cell
1
2011
620
0.060
Why?
Cytosol
1
2006
215
0.060
Why?
Mycophenolic Acid
1
2006
89
0.060
Why?
HEK293 Cells
2
2018
681
0.060
Why?
Administration, Inhalation
1
2007
661
0.060
Why?
Calcium-Calmodulin-Dependent Protein Kinases
1
2006
181
0.060
Why?
Organ Size
2
2016
440
0.060
Why?
MicroRNAs
1
2012
674
0.060
Why?
Amino Acid Sequence
2
2020
2042
0.060
Why?
Conotoxins
1
2005
14
0.060
Why?
High-Throughput Nucleotide Sequencing
2
2019
484
0.060
Why?
Pulmonary Surfactant-Associated Protein D
1
2025
35
0.060
Why?
Isotopes
2
2015
28
0.060
Why?
Enzyme Inhibitors
1
2009
809
0.060
Why?
Electrophoresis, Polyacrylamide Gel
2
2019
328
0.060
Why?
Cognition
2
2021
1104
0.060
Why?
Calcium Channels, L-Type
1
2006
113
0.060
Why?
Receptors, Neurotransmitter
1
2004
16
0.060
Why?
Prone Position
1
2024
30
0.060
Why?
Supine Position
1
2024
38
0.060
Why?
Colorado
4
2019
4369
0.060
Why?
Length of Stay
1
2010
1114
0.060
Why?
Calcineurin
1
2005
91
0.060
Why?
Skin Neoplasms
1
2012
818
0.060
Why?
Multiple Chronic Conditions
1
2024
28
0.060
Why?
Immunoprecipitation
2
2018
157
0.060
Why?
Protein Structure, Quaternary
1
2004
122
0.060
Why?
Epilepsy
1
2008
322
0.060
Why?
Nitrates
1
2004
87
0.060
Why?
Synaptic Transmission
1
2006
258
0.060
Why?
Granuloma
1
2004
83
0.060
Why?
Academic Medical Centers
1
2007
478
0.050
Why?
Ventricular Function, Right
1
2006
274
0.050
Why?
Residual Volume
1
2023
6
0.050
Why?
Microscopy, Fluorescence
1
2005
399
0.050
Why?
Cell Survival
2
2007
1073
0.050
Why?
Pulmonary Veins
1
2024
93
0.050
Why?
Monoamine Oxidase
1
2003
27
0.050
Why?
Smoking Cessation
2
2018
407
0.050
Why?
Enzyme Activation
1
2005
796
0.050
Why?
Textile Industry
1
2003
1
0.050
Why?
Gene Expression
3
2017
1454
0.050
Why?
Minisatellite Repeats
1
2003
40
0.050
Why?
Amino Acid Substitution
2
2019
280
0.050
Why?
Anti-Inflammatory Agents, Non-Steroidal
1
2006
332
0.050
Why?
Tomography
1
2023
24
0.050
Why?
Texas
1
2024
227
0.050
Why?
Dopamine Plasma Membrane Transport Proteins
1
2003
47
0.050
Why?
Chloride Channel Agonists
1
2023
77
0.050
Why?
Unsupervised Machine Learning
1
2022
17
0.050
Why?
Muscle Spasticity
1
2023
55
0.050
Why?
Dizocilpine Maleate
1
2002
14
0.050
Why?
Coenzyme A
1
2022
8
0.050
Why?
Induced Pluripotent Stem Cells
2
2016
221
0.050
Why?
Phosphatidylglycerols
1
2022
24
0.050
Why?
Cysteine Proteinase Inhibitors
1
2002
47
0.050
Why?
3-Hydroxybutyric Acid
1
2022
14
0.050
Why?
Antacids
1
2022
14
0.050
Why?
Sulfur
1
2022
50
0.050
Why?
Neurosecretory Systems
1
2002
31
0.050
Why?
DNA, Complementary
1
2002
266
0.050
Why?
Lymphocytes
2
2017
367
0.050
Why?
Silicosis
1
2002
27
0.050
Why?
Carnitine
1
2022
76
0.050
Why?
Cardiovascular Diseases
1
2014
1994
0.050
Why?
Protein Processing, Post-Translational
1
2004
451
0.050
Why?
Research
1
2005
408
0.050
Why?
Ceramides
1
2022
104
0.050
Why?
5' Untranslated Regions
1
2021
55
0.050
Why?
Pulmonologists
1
2021
15
0.050
Why?
Australia
1
2022
243
0.050
Why?
Oxygen
2
2023
899
0.050
Why?
Scoliosis
1
2024
201
0.050
Why?
Probability
1
2022
304
0.050
Why?
Hyperplasia
1
2002
170
0.050
Why?
Benchmarking
1
2023
175
0.050
Why?
Prefrontal Cortex
1
2004
299
0.050
Why?
Belgium
1
2021
12
0.050
Why?
Aldehyde Oxidoreductases
1
2021
27
0.050
Why?
Oligonucleotides, Antisense
1
2021
106
0.050
Why?
Poland
1
2021
33
0.050
Why?
Cell Differentiation
3
2016
1896
0.050
Why?
Spain
1
2021
34
0.050
Why?
Calcium-Binding Proteins
1
2002
209
0.050
Why?
Fractals
1
2021
8
0.050
Why?
Finland
1
2021
90
0.040
Why?
Protein Array Analysis
1
2021
56
0.040
Why?
3' Untranslated Regions
1
2021
139
0.040
Why?
Protective Factors
1
2021
91
0.040
Why?
Germany
1
2021
97
0.040
Why?
Sweden
1
2021
92
0.040
Why?
Oxygen Consumption
1
2024
669
0.040
Why?
New York
1
2021
124
0.040
Why?
Family
1
2025
648
0.040
Why?
Surface-Active Agents
1
2021
83
0.040
Why?
Iceland
1
2020
10
0.040
Why?
Endpoint Determination
2
2011
75
0.040
Why?
Observational Studies as Topic
1
2021
108
0.040
Why?
Transcription, Genetic
1
2007
1403
0.040
Why?
Neuropsychological Tests
2
2021
1001
0.040
Why?
Risk Adjustment
1
2021
79
0.040
Why?
Polymerase Chain Reaction
1
2003
1020
0.040
Why?
Iron
1
2022
282
0.040
Why?
Hemodynamics
2
2021
1077
0.040
Why?
Mortality
1
2002
306
0.040
Why?
Air
1
2020
36
0.040
Why?
Canada
1
2021
344
0.040
Why?
Sequence Analysis, DNA
2
2013
771
0.040
Why?
Triglycerides
1
2022
523
0.040
Why?
Tobacco Smoke Pollution
2
2014
229
0.040
Why?
Liquid Biopsy
1
2019
8
0.040
Why?
Anthropometry
1
2020
204
0.040
Why?
Image Enhancement
1
2020
163
0.040
Why?
Macaca fascicularis
1
2019
49
0.040
Why?
Ireland
1
2019
27
0.040
Why?
Antibody Specificity
1
2019
182
0.040
Why?
Hospitals
1
2024
631
0.040
Why?
Acrylamides
1
2019
58
0.040
Why?
Dermatomyositis
1
2019
26
0.040
Why?
Molecular Weight
1
2019
331
0.040
Why?
Reference Standards
1
2019
168
0.040
Why?
Fingers
1
2019
86
0.040
Why?
Aniline Compounds
1
2019
96
0.040
Why?
Iowa
1
2018
24
0.040
Why?
Magnetoencephalography
1
2019
128
0.040
Why?
Histones
2
2015
585
0.040
Why?
Dental Hygienists
1
2018
11
0.040
Why?
Treatment Failure
1
2019
338
0.040
Why?
Real-Time Polymerase Chain Reaction
1
2019
323
0.040
Why?
Job Description
1
2018
14
0.040
Why?
Pyrimidines
1
2022
446
0.040
Why?
A549 Cells
1
2018
57
0.040
Why?
Primary Cell Culture
1
2018
157
0.040
Why?
Hep G2 Cells
1
2018
61
0.040
Why?
Species Specificity
1
2019
568
0.040
Why?
Acetylation
1
2018
242
0.040
Why?
Simvastatin
1
2018
54
0.040
Why?
Gene Ontology
1
2017
48
0.040
Why?
Factor Analysis, Statistical
1
2018
283
0.040
Why?
Betacoronavirus
1
2020
247
0.040
Why?
Pregnancy
1
2010
6355
0.040
Why?
Patient Discharge
1
2024
850
0.040
Why?
Neural Pathways
1
2019
292
0.030
Why?
Rheumatology
1
2019
106
0.030
Why?
Netherlands
1
2017
77
0.030
Why?
Death Certificates
1
2017
30
0.030
Why?
Syndrome
2
2009
332
0.030
Why?
Telomerase
1
2019
231
0.030
Why?
National Heart, Lung, and Blood Institute (U.S.)
1
2017
101
0.030
Why?
Forecasting
1
2019
355
0.030
Why?
Phosphocreatine
1
2016
40
0.030
Why?
Signal Transduction
2
2007
4812
0.030
Why?
Heart
1
2020
637
0.030
Why?
Models, Anatomic
1
2017
88
0.030
Why?
Bronchial Neoplasms
1
2016
14
0.030
Why?
Neoplasm Recurrence, Local
1
2002
955
0.030
Why?
Uncertainty
1
2017
114
0.030
Why?
Tracheal Neoplasms
1
2016
10
0.030
Why?
Radiation Protection
1
2016
36
0.030
Why?
Papilloma
1
2016
46
0.030
Why?
Victoria
1
2016
16
0.030
Why?
Calcium
1
2002
1182
0.030
Why?
Chromosomes, Human, Pair 6
1
2016
51
0.030
Why?
Antirheumatic Agents
1
2019
278
0.030
Why?
Pneumonia, Pneumocystis
1
2016
34
0.030
Why?
Phantoms, Imaging
1
2017
137
0.030
Why?
Amyloidosis
1
2016
39
0.030
Why?
Inhalation
1
2016
28
0.030
Why?
Asbestosis
1
2015
13
0.030
Why?
Rheumatoid Factor
1
2017
167
0.030
Why?
ErbB Receptors
1
2019
601
0.030
Why?
Magnetic Resonance Imaging, Cine
1
2017
184
0.030
Why?
Xenon Isotopes
1
2015
3
0.030
Why?
Helium
1
2015
6
0.030
Why?
Fluorine
1
2015
15
0.030
Why?
Linkage Disequilibrium
1
2016
256
0.030
Why?
Causality
1
2016
115
0.030
Why?
Thoracic Surgical Procedures
1
2016
69
0.030
Why?
Phosphodiesterase 5 Inhibitors
1
2015
36
0.030
Why?
Cell Nucleus
1
2018
579
0.030
Why?
Serpins
1
2015
31
0.030
Why?
Markov Chains
1
2015
116
0.030
Why?
Mitochondria, Muscle
1
2016
110
0.030
Why?
Biological Specimen Banks
1
2016
96
0.030
Why?
Aconitate Hydratase
1
2015
17
0.030
Why?
Recurrence
2
2012
993
0.030
Why?
GTPase-Activating Proteins
1
2015
81
0.030
Why?
Physical Examination
1
2016
230
0.030
Why?
Software
1
2020
606
0.030
Why?
Zinc Fingers
1
2015
43
0.030
Why?
K562 Cells
1
2015
82
0.030
Why?
Specimen Handling
1
2016
163
0.030
Why?
Respiratory Physiological Phenomena
1
2014
30
0.030
Why?
Endodeoxyribonucleases
1
2015
67
0.030
Why?
Perfusion
1
2015
188
0.030
Why?
Multilingualism
1
2014
26
0.030
Why?
Hemochromatosis Protein
1
2014
3
0.030
Why?
Acyl Coenzyme A
1
2013
30
0.030
Why?
Clinical Trials, Phase III as Topic
1
2014
92
0.030
Why?
Mexico
1
2014
190
0.030
Why?
Respiratory Mucosa
1
2016
304
0.030
Why?
Nitrogen Isotopes
1
2013
58
0.030
Why?
Propionates
1
2013
34
0.030
Why?
Nutrition Surveys
1
2015
261
0.030
Why?
Computer Simulation
1
2018
936
0.030
Why?
Computational Biology
1
2018
595
0.030
Why?
Patient Education as Topic
1
2018
733
0.030
Why?
Models, Organizational
1
2014
145
0.030
Why?
Isotope Labeling
1
2013
73
0.030
Why?
Esters
1
2013
74
0.030
Why?
Patient Safety
1
2016
286
0.030
Why?
Carbon Isotopes
1
2013
123
0.030
Why?
Chromosomes, Human
1
2013
41
0.030
Why?
Hypercholesterolemia
1
2014
101
0.030
Why?
Tumor Suppressor Proteins
1
2015
313
0.030
Why?
Mental Recall
1
2014
185
0.030
Why?
APACHE
1
2013
65
0.030
Why?
Swine
1
2015
742
0.030
Why?
Health Services
1
2013
97
0.030
Why?
Biomarkers, Tumor
1
2019
1175
0.030
Why?
Observation
1
2012
51
0.030
Why?
Postoperative Complications
1
2024
2456
0.030
Why?
Receptor, Angiotensin, Type 1
1
2012
21
0.030
Why?
False Negative Reactions
1
2012
50
0.020
Why?
Drug Therapy, Combination
1
2015
1012
0.020
Why?
Aortography
1
2012
51
0.020
Why?
Disease Management
1
2016
583
0.020
Why?
Congresses as Topic
1
2013
211
0.020
Why?
False Positive Reactions
1
2012
113
0.020
Why?
Mixed Connective Tissue Disease
1
2012
9
0.020
Why?
Arthrography
1
2011
17
0.020
Why?
Anti-Bacterial Agents
1
2022
1689
0.020
Why?
Antigens, CD34
1
2012
89
0.020
Why?
Graves Disease
1
2012
35
0.020
Why?
Genetic Counseling
1
2012
71
0.020
Why?
Herpesvirus 8, Human
1
2012
59
0.020
Why?
Gene Frequency
1
2013
504
0.020
Why?
Repetitive Sequences, Nucleic Acid
1
2012
111
0.020
Why?
Odds Ratio
1
2014
1018
0.020
Why?
Pedigree
1
2013
485
0.020
Why?
Exome
1
2012
220
0.020
Why?
Sulfhydryl Compounds
1
2013
186
0.020
Why?
Education
1
2012
100
0.020
Why?
Chromosome Mapping
1
2012
504
0.020
Why?
Neoplasms
2
2021
2460
0.020
Why?
Caspase 1
1
2012
141
0.020
Why?
Oligonucleotide Array Sequence Analysis
1
2013
755
0.020
Why?
Glucocorticoids
1
2015
572
0.020
Why?
Veterans
1
2002
1397
0.020
Why?
Drug Synergism
1
2012
356
0.020
Why?
Joints
1
2011
95
0.020
Why?
Latin America
1
2011
86
0.020
Why?
Electrophoresis, Gel, Two-Dimensional
1
2010
97
0.020
Why?
NLR Family, Pyrin Domain-Containing 3 Protein
1
2012
149
0.020
Why?
Quality-Adjusted Life Years
1
2010
106
0.020
Why?
Diabetes Complications
1
2012
223
0.020
Why?
Chest Pain
1
2010
89
0.020
Why?
Alanine-tRNA Ligase
1
2009
4
0.020
Why?
Threonine-tRNA Ligase
1
2009
4
0.020
Why?
Cell Line, Tumor
2
2007
3168
0.020
Why?
Placebos
1
2009
201
0.020
Why?
Administration, Oral
1
2011
766
0.020
Why?
Minority Groups
1
2010
250
0.020
Why?
DNA Topoisomerases, Type I
1
2008
14
0.020
Why?
Structural Homology, Protein
1
2008
25
0.020
Why?
Apelin Receptors
1
2007
4
0.020
Why?
Specialization
1
2009
144
0.020
Why?
Intensive Care Units
1
2013
734
0.020
Why?
Apelin
1
2007
9
0.020
Why?
raf Kinases
1
2007
11
0.020
Why?
Epigenesis, Genetic
1
2012
614
0.020
Why?
Pulmonary Wedge Pressure
1
2007
66
0.020
Why?
3,4-Dihydroxyphenylacetic Acid
1
2006
19
0.020
Why?
Velopharyngeal Insufficiency
1
2006
12
0.020
Why?
Catechols
1
2006
14
0.020
Why?
Extracellular Signal-Regulated MAP Kinases
1
2007
163
0.020
Why?
RNA
1
2013
881
0.020
Why?
Nerve Degeneration
1
2006
44
0.020
Why?
Levodopa
1
2006
29
0.020
Why?
Tyrosine 3-Monooxygenase
1
2006
73
0.020
Why?
Interprofessional Relations
1
2009
270
0.020
Why?
Parkinsonian Disorders
1
2006
36
0.020
Why?
Decision Making
1
2013
846
0.020
Why?
Solubility
1
2006
232
0.020
Why?
Drug Industry
1
2007
106
0.020
Why?
Patient Compliance
1
2010
558
0.020
Why?
Cell Death
1
2007
342
0.020
Why?
Intercellular Signaling Peptides and Proteins
1
2007
371
0.020
Why?
Tretinoin
1
2006
127
0.020
Why?
Medical Records
1
2006
170
0.020
Why?
Receptors, G-Protein-Coupled
1
2007
204
0.020
Why?
Neuroblastoma
1
2006
153
0.020
Why?
Proto-Oncogene Proteins c-akt
1
2007
419
0.020
Why?
Receptor, TIE-2
1
2004
12
0.010
Why?
Hypertension
1
2014
1234
0.010
Why?
Models, Genetic
1
2008
591
0.010
Why?
Excitatory Amino Acid Transporter 2
1
2004
15
0.010
Why?
Cardiomegaly
1
2006
168
0.010
Why?
Synucleins
1
2004
7
0.010
Why?
Skin
1
2009
711
0.010
Why?
Mutation, Missense
1
2006
315
0.010
Why?
Immunotherapy
1
2009
586
0.010
Why?
Valine
1
2004
80
0.010
Why?
Cell Count
1
2004
310
0.010
Why?
Methionine
1
2004
157
0.010
Why?
Proteasome Endopeptidase Complex
1
2004
145
0.010
Why?
Recombinant Fusion Proteins
1
2006
634
0.010
Why?
Protein Conformation
1
2006
853
0.010
Why?
Nuclear Proteins
1
2008
657
0.010
Why?
Molecular Chaperones
1
2004
181
0.010
Why?
Health Services Needs and Demand
1
2005
262
0.010
Why?
Oxidation-Reduction
1
2006
1001
0.010
Why?
Colorectal Neoplasms
1
2010
746
0.010
Why?
Prostatic Neoplasms
1
2010
1011
0.010
Why?
Lung Diseases, Parasitic
1
2002
1
0.010
Why?
Rats, Sprague-Dawley
1
2007
2258
0.010
Why?
HIV-1
1
2007
833
0.010
Why?
Hospitals, Veterans
1
2002
255
0.010
Why?
Lipid Metabolism
1
2004
491
0.010
Why?
Sputum
1
2002
301
0.010
Why?
Risk
1
2002
850
0.010
Why?
Protein Binding
1
2004
2105
0.010
Why?
Lynch's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)